| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 08/03/2010 | CA2441792C Carboline derivatives as inhibitors of phosphodiesterase 5 (pdes) for the treatment of cardiovascular diseases and erectile dysfunction |
| 08/03/2010 | CA2409828C Formulation based in heparin, glycosaminoglycan or heparinoid, use of the formulation and the formulation base |
| 08/03/2010 | CA2402199C Amidino compounds useful as nitric oxide synthase inhibitors |
| 08/03/2010 | CA2306343C Novel aryloxy-alkyl-dialkylamines |
| 07/29/2010 | WO2010085262A1 In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors |
| 07/29/2010 | WO2010084999A1 Immunosuppressive agents and prophylactic and therapeutic agents for autoimmune diseases |
| 07/29/2010 | WO2010084851A1 Peptide capable of binding to immunoglobulin |
| 07/29/2010 | WO2010084767A1 N-substituted saturated heterocyclic sulfone compounds with cb2 receptor agonistic activity |
| 07/29/2010 | WO2010084668A1 Diagnostic method for nephrotic syndrome, prophylactic or therapeutic agent for nephrotic syndrome, and method for screening the prophylactic or therapeutic agent |
| 07/29/2010 | WO2010083573A1 The treatment or prophylaxis of organ and tissue fibrosis via modulation of cell division autoantigen (cda1) |
| 07/29/2010 | WO2010020307A3 Indazole-5-carboxylic acid hydrazide derivatives |
| 07/29/2010 | US20100190964 Antibodies to human ErbB4 |
| 07/29/2010 | US20100190838 Connective Tissue Growth Factor Fragments and Methods and Uses Thereof |
| 07/29/2010 | US20100190830 (3-Amino-1,2,3,4-Tetrahydro-9H-Carbazol-9-yl)-Acetic Acid Derivatives |
| 07/29/2010 | US20100190821 3,8-substituted 8-aza-bicyclo[3.2.1]octane derivatives and their use as monomine neurotransmitter re-uptake inhibitors |
| 07/29/2010 | US20100190788 Amide derivatives as kinase inhitors |
| 07/29/2010 | US20100190770 Compositions and methods for inhibition of the jak pathway |
| 07/29/2010 | US20100190759 Nk 1 antagonists |
| 07/29/2010 | US20100190743 Method and Composition for Treatment of a Mucosal Tissue Disorder |
| 07/29/2010 | US20100190717 Use of melanin concentrating hormone and met-enkephalin as therapeutic agents |
| 07/29/2010 | US20100190684 Inhibition of palmitoyl acyl transferase expression and/or activity for the regulation of antiproliferative factor activity |
| 07/29/2010 | US20100189786 Crystalline tolterodine tartarate and a pharmaceutical composition containing the same |
| 07/29/2010 | US20100189720 Novel card proteins involved in cell death regulation |
| 07/29/2010 | US20100189695 Irak-1 as regulator of diseases and disorders |
| 07/29/2010 | US20100189686 Albumin Fusion Proteins |
| 07/29/2010 | US20100189682 Biologically active proteins having increased In Vivo and/or In Vitro stability |
| 07/29/2010 | US20100189659 Diagnostic substance and method for the diagnosis of prostate diseases |
| 07/29/2010 | DE10392697B4 Extrakt von Peptid-verknüpften Glucanen und Peptid-verknüpfte Clucane mit nachweisbarer oraler Resorbierbarkeit aus Coriolus Versicolor und deren Reinigungsverfahren und Verwendungen Extract of peptide-linked glucans and peptide-linked Clucane with detectable oral absorbability from Coriolus versicolor and their cleaning methods and uses |
| 07/29/2010 | CA2747801A1 N-substituted saturated heterocyclic sulfone compounds with cb2 receptor agonistic activity |
| 07/28/2010 | EP2210605A1 Once daily dosage forms of trospium |
| 07/28/2010 | EP2210603A1 Pharmaceutical composition for inhibiting the accumulation of amyloid- b protein |
| 07/28/2010 | EP2209473A1 Method of treating polycystic kidney diseases with ceramide derivatives |
| 07/28/2010 | EP1954677B1 Thiomorpholine compound and process for preparing the same |
| 07/28/2010 | EP1574218B1 A medicament containing epimedium extract for treatment of prostatic hyperplasia and prostatitis |
| 07/28/2010 | EP1458392B9 Acridones as inhibitors of impdh enzyme |
| 07/28/2010 | CN101787073A Methods and compositions for the treatment of gastrointestinal disorders |
| 07/28/2010 | CN101787063A Anti-infective medicament and preparation and application thereof |
| 07/28/2010 | CN101785834A Traditional Chinese medicine combination and preparation method thereof for renal insufficiency treatment |
| 07/28/2010 | CN101785833A External traditional Chinese medicine compound extract for repairing and treating renal injury and preparation method thereof |
| 07/28/2010 | CN101785827A Chinese medicament for curing prostatitis |
| 07/28/2010 | CN101785776A Application of ergot sterone in preparation of medicaments for treating chronic renal failure |
| 07/28/2010 | CN101461805B Use of anti-hantavirus medicament arbidol |
| 07/28/2010 | CN101020033B Medicine for treating renal calculus |
| 07/27/2010 | US7763729 Bicyclic heteroaromatic derivatives |
| 07/27/2010 | US7763716 monoclonal antibodies capable of recognizing and neutralizing neuropeptide W (NPW) an endogenous ligands for human G protein coupled receptors, used in the medical diagnosis and preventing of infertility, kidney edema, peptic ulcer, gastric hyperacidity |
| 07/27/2010 | US7763621 3-[[6-[4-(1,2,3,4-tetrahydro-1,8-naphthyridin-7-yl)-1-piperidinyl]-2,5-dimethyl-4-pyrimidinyl]amino]-N-[(phenylmethoxy)carbonyl]alanine, used for the treatment of osteoporosis, restenosis, arteriosclerosis, nephropathy or retinopathy |
| 07/27/2010 | US7763284 Method for treating or preventing symptoms associated with menopause |
| 07/27/2010 | US7763243 Arming of activated T cells with BiAbs increases the effective precursor frequency of CTL in the cancer patient. |
| 07/27/2010 | CA2629339C Pyrazolo[4,3-d]pyrimidin-5-yl) derivative used as pde5 inhibitors |
| 07/27/2010 | CA2610166C Benzoquinolinesulfonamide derivatives useful as rho-kinase inhibitors |
| 07/27/2010 | CA2470105C Substituted 6h-dibenzo[c,h]chromenes as estrogenic agents |
| 07/27/2010 | CA2445625C Pyrazino'1',2':1,6!pyrido'3,4-b!indole1,4-dione derivatives |
| 07/27/2010 | CA2436659C Cannabinoid receptor ligands |
| 07/27/2010 | CA2323091C Nephrin gene and protein |
| 07/22/2010 | WO2010082601A1 Novel 2,5-disubstituted pyrrole derivative |
| 07/22/2010 | WO2010081264A1 Pharmaceutical composition for preventing and treating diabetic nephropathy and preparation method thereof |
| 07/22/2010 | WO2010081263A1 A pharmaceutical composition for treating diabetic nephropathy and the preparation method and use thereof |
| 07/22/2010 | WO2010081262A1 A pharmaceutical composition for treating diabetic nephropathy and the preparation method and use thereof |
| 07/22/2010 | WO2010047765A3 Nanostructures for drug delivery |
| 07/22/2010 | US20100184862 Prostacyclin derivatives |
| 07/22/2010 | US20100184850 Phenolic extracts of almond peel containing procyanidins, propelargonidins, and prodelphinidins, and method for preparation thereof |
| 07/22/2010 | US20100184825 for treating, preventing, inhibiting, or reducing obesity, insulin resistance, diabetes and any other disease, trait, or condition that is related to or will respond to the levels of PTP-1B in a cell or tissue |
| 07/22/2010 | US20100184809 Heterocyclic FXR Binding Compounds |
| 07/22/2010 | US20100184790 Pyrrolo[2,3-b]pyridine compounds, azaindole compounds used for synthesizing said pyrrolo[2,3-b]pyridine compounds, methods for the production thereof, and uses thereof |
| 07/22/2010 | US20100184774 Methods of treatment |
| 07/22/2010 | US20100184749 Benzothiadiazine compounds and their use |
| 07/22/2010 | US20100184730 Fatty Acid Acylated Salicylates and Their Uses |
| 07/22/2010 | US20100184718 Compositions and Methods for Double-Targeting Virus Infections and Targeting Cancer Cells |
| 07/22/2010 | US20100184701 Beta-Arrestin Effectors And Compositions And Methods Of Use Thereof |
| 07/22/2010 | US20100184690 Combined Use Of A GLP-1 Compound And A Modulator Of Diabetic Late Complications |
| 07/22/2010 | US20100184676 Use of a peptide as a therapeutic agent |
| 07/22/2010 | US20100183717 Controlled-release formulations |
| 07/22/2010 | US20100183712 Acylated indanyl amines and their use as pharmaceuticals |
| 07/22/2010 | US20100183709 Formulation |
| 07/22/2010 | US20100183609 Taci-immunoglobulin fusion proteins |
| 07/21/2010 | EP2208499A1 Nucleic acid capable of regulating the proliferation of cell |
| 07/21/2010 | EP1487444B9 Use of pyridyl amides as inhibitors of angiogenesis |
| 07/21/2010 | EP1259243B2 Bupropion metabolites and methods of their synthesis and use |
| 07/21/2010 | CN1960977B Quinazoline derivative |
| 07/21/2010 | CN1730034B Pharmaceutical composition for treating acute pneumonia, urinary tract infection and cholecystitis |
| 07/21/2010 | CN101781364A Interleukin-1 receptor antagonist |
| 07/21/2010 | CN101781287A Irbesartan hydrobromide and preparation method thereof |
| 07/21/2010 | CN101780240A Essence, qi, and blood-strengthening pills and capsules |
| 07/21/2010 | CN101780221A Kidney-tonifying and yang-strengthening medicinal liquor preparation and preparation method thereof |
| 07/21/2010 | CN101780201A Kidney-tonifying and yang-strengthening oral solution and preparation method thereof |
| 07/21/2010 | CN101780188A Capsule for treating prostatic diseases |
| 07/21/2010 | CN101780127A Ajowan-caraway seedchewable tablet and preparation method thereof |
| 07/21/2010 | CN101780077A Application of Amlodipine to preparation of medicines for treating renal toxicity caused by gentamicin |
| 07/21/2010 | CN101780070A Pharmaceutical composition for treating diabetic nephropathy and preparation method and application thereof |
| 07/21/2010 | CN101780069A Drug composite for preventing diabetic nephropathy and preparation method thereof |
| 07/21/2010 | CN101780067A Pharmaceutical composition for treating diabetic nephropathy and preparation method and application |
| 07/21/2010 | CN101780062A Application of resveratrol to treating kidney disease |
| 07/21/2010 | CN101780054A Compound sustained-release preparation and preparation method thereof |
| 07/21/2010 | CN101244219B Chinese medicine powder medicine for treating prostate gland |
| 07/21/2010 | CN101190308B Ginseng deer kidney-invigorating traditional Chinese medicine preparation and preparation method thereof |
| 07/21/2010 | CN101129200B Inducing astringency cake and producing technique of the same |
| 07/20/2010 | US7759486 2,4,5-Trisubstituted pyrimidine compounds |
| 07/20/2010 | US7759380 Substituted pyrrolines as kinase inhibitors |
| 07/20/2010 | US7759373 nitrogen-containing 5-membered heterocyclic compound |
| 07/20/2010 | US7759367 Pharmaceutical compositions and their uses |